<DOC>
	<DOCNO>NCT00583479</DOCNO>
	<brief_summary>The purpose prospective randomize study compare clinical effectiveness EUS-guided CB perform single injection versus two injection medication celiac ganglion region .</brief_summary>
	<brief_title>Prospective Study Celiac Block Injection : 1 vs. 2</brief_title>
	<detailed_description />
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Pancreatitis</mesh_term>
	<mesh_term>Pancreatitis , Chronic</mesh_term>
	<criteria>Patients chronic abdominal pain document chronic pancreatitis pancreatic cancer refer EUSguided celiac block eligible participate study . Chronic pancreatitis pancreatic cancer must measure documented prior CT , ERCP , EUS . Patients significant comorbidities uncontrolled heart failure , severe chronic obstructive pulmonary disease ( COPD ) would limit survivability sedation give procedure . Age &gt; = 18 year No evidence significant active infection ( ie . pneumonia , peritonitis , wound sepsis , etc ) No evidence serious ongoing illness uncontrolled metabolic disease ( diabetes mellitus , hypothyroidism , etc ) No evidence dementia alter mental status would prohibit give understand informed consent , evidence psychiatric risk would preclude adequate compliance protocol . Patient must provide sign write informed consent . Patients previous celiac plexus block eligible study The patient 's celiac trunk image clearly endoscopic ultrasound . The patient 's celiac plexus access easily needle medication injection . If do safely due patient 's anatomy ( intervene blood vessel tumor ) , patient eligible procedure study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2012</verification_date>
</DOC>